- Capricor CFO Anthony Bergmann reported sale of 25,000 shares on March 31.
- Disposition priced at USD 30.13 per share on weighted-average basis.
- Filing also showed exercise of options for 25,000 shares at USD 3.18 per share.
- Holdings in common stock fell to 8,223 shares following transactions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capricor Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001593087-26-000005), on April 01, 2026, and is solely responsible for the information contained therein.
Comments